About Uvantis Therapeutics
Uvantis Therapeutics is a private company based in Columbia, Maryland, incorporated in 2025 in Delaware. It has reported $100,000 raised in one offering on Form D since September 2026.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Sep 23, 2026 | $100,000of $5.0M target | 1 | $100K | Debt, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Uvantis Therapeutics's Form D filed Sep 23, 2026.
JY
Jonathan Young
Director
EW
Edward Woo
Director
WS
William Sheahan
Director
PG
Paul Giannasca
Executive officer
JC
Jeffrey Collins
Executive officer